Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction.

[1]  R. D. de Boer,et al.  Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin , 2010, Journal of Molecular Medicine.

[2]  A. Coats,et al.  Ethics in the authorship and publishing of scientific articles , 2010 .

[3]  D. J. Veldhuisen,et al.  Bone marrow dysfunction in chronic heart failure patients , 2010, European journal of heart failure.

[4]  G. Karanikas,et al.  Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume. , 2008, European heart journal.

[5]  A. Voors,et al.  Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. , 2008, European heart journal.

[6]  S. Katz,et al.  Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options , 2006, Circulation.

[7]  C. Marth,et al.  Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. , 2006, Blood.

[8]  D. Wojchowski,et al.  Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. , 2006, The Journal of clinical investigation.

[9]  M. Cazzola,et al.  Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. , 2005, European heart journal.

[10]  I C Macdougall,et al.  Hyporesponsiveness to erythropoietic therapy due to chronic inflammation , 2005, European journal of clinical investigation.

[11]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[12]  H. Makino,et al.  The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients. , 2004, Journal of the American Society of Nephrology : JASN.

[13]  Leo Koenderman,et al.  Signal transducer and activator of transcription 5 (STAT5). , 2004, The international journal of biochemistry & cell biology.

[14]  M. Jongen‐Lavrencic,et al.  R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis , 1994, Rheumatology International.

[15]  C. D. dos Remedios,et al.  Activation of signal transducer and activator of transcription (STAT) pathways in failing human hearts. , 2003, Cardiovascular research.

[16]  J. Fisher,et al.  Erythropoietin: Physiology and Pharmacology Update 2 , 2003, Experimental biology and medicine.

[17]  Jie-shou Li,et al.  The role of endotoxin, TNF-α α α α α , and IL-6 in inducing the state of growth hormone insensitivity , 2002 .

[18]  P. Poole‐Wilson,et al.  Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. , 2001, Journal of the American College of Cardiology.

[19]  R. Riley,et al.  Reticulocytes and reticulocyte enumeration , 2001, Journal of clinical laboratory analysis.

[20]  R. Gregory,et al.  Signal transduction in the erythropoietin receptor system. , 1999, Experimental cell research.

[21]  H. Lodish,et al.  Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice A Direct Role for Stat5 in Bcl-XL Induction , 1999, Cell.

[22]  I. Macdougall,et al.  Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-gamma and TNF-alpha. , 1999, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[23]  A. Cumano,et al.  Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis , 1998, Cell.

[24]  A. Mode,et al.  Desensitization of the Growth Hormone-Induced Janus Kinase 2 (Jak 2)/Signal Transducer and Activator of Transcription 5 (Stat5)-Signaling Pathway Requires Protein Synthesis and Phospholipase C. , 1998, Endocrinology.

[25]  L. Pfeffer,et al.  Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. , 1998, Journal of immunology.

[26]  J. Price,et al.  Interferon γ Downregulates Stem Cell Factor and Erythropoietin Receptors But Not Insulin-Like Growth Factor-I Receptors in Human Erythroid Colony-Forming Cells , 1997 .

[27]  S. Anker,et al.  Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. , 1997, Journal of the American College of Cardiology.

[28]  A. Dowlati,et al.  Anaemia of lung cancer is due to impaired erythroid marrow response to erythropoietin stimulation as well as relative inadequacy of erythropoietin production , 1997, British journal of haematology.

[29]  D. Waxman,et al.  Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation. , 1997, Molecular endocrinology.

[30]  S. Busfield,et al.  Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[31]  Rudolf Jaenisch,et al.  Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.

[32]  Ursula Klingmüller,et al.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.

[33]  G. Condorelli,et al.  Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. , 1994, The American journal of cardiology.

[34]  M. Koury,et al.  Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. , 1993, Blood.

[35]  H. Lodish,et al.  Structure, function, and activation of the erythropoietin receptor. , 1993, Blood.